-
Advances and Applications in Bioinformatics and Chemistry
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
A simple method for assessing the strength of evidence for association at the level of the whole gene
Original Research
(3224) Views (797) Full article downloads
Authors: David Curtis, Anna E Vine, Jo Knight
Published Date November 2008
Volume 2008:1 Pages 115 - 120
DOI: http://dx.doi.org/10.2147/AABC.S4095
David Curtis1, Anna E Vine1, Jo Knight2
1Centre for Psychiatry, Queen Mary’s School of Medicine and Dentistry, London E1 1BB, UK; 2Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK
Introduction: It is expected that different markers may show different patterns of association with different pathogenic variants within a given gene. It would be helpful to combine the evidence implicating association at the level of the whole gene rather than just for individual markers or haplotypes. Doing this is complicated by the fact that different markers do not represent independent sources of information.
Method: We propose combining the p values from all single locus and/or multilocus analyses of different markers according to the formula of Fisher, X = Σ(−2ln(pi)), and then assessing the empirical significance of this statistic using permutation testing. We present an example application to 19 markers around the HTRA2 gene in a case-control study of Parkinson’s disease.
Results: Applying our approach shows that, although some individual tests produce low p values, overall association at the level of the gene is not supported.
Discussion: Approaches such as this should be more widely used in assimilating the overall evidence supporting involvement of a gene in a particular disease. Information can be combined from biallelic and multiallelic markers and from single markers along with multimarker analyses. Single genes can be tested or results from groups of genes involved in the same pathway could be combined in order to test biologically relevant hypotheses. The approach has been implemented in a computer program called COMBASSOC which is made available for downloading.
Keywords: Fisher, significance, genetic marker
Other articles by Professor David Curtis
Patient experience – the ingredient missing from cost-effectiveness calculations- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells
- Discrimination between biological interfaces and crystal-packing contacts




